Cargando…
Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD
Autores principales: | Xie, Kangzhe, Ortiz Cerda, Tamara, Schroder, Angie, Shiung, Nicolette, Lemos Wimmer, Bruno, Chami, Belal, Witting, Paul K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393069/ https://www.ncbi.nlm.nih.gov/pubmed/37527412 http://dx.doi.org/10.1093/ibd/izad133 |
Ejemplares similares
-
Myeloperoxidase in Health and Disease
por: Ortiz-Cerda, Tamara, et al.
Publicado: (2023) -
Neutrophil Extracellular Trap Density Increases With Increasing Histopathological Severity of Crohn’s Disease
por: Schroder, Angie L, et al.
Publicado: (2021) -
The Synthetic Myeloperoxidase Inhibitor AZD3241 Ameliorates Dextran Sodium Sulfate Stimulated Experimental Colitis
por: Ahmad, Gulfam, et al.
Publicado: (2020) -
Indicator of Inflammation and NETosis—Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2022) -
The Role of Thiocyanate in Modulating Myeloperoxidase Activity during Disease
por: San Gabriel, Patrick T., et al.
Publicado: (2020)